Senior Associate Consultant and Assistant Professor, Mayo Clinic
BIOGRAPHY
Speaker
Event Date & Time
Date: June 18, 2024
Time: 8:00 AM (PDT), 11:00 AM (EDT), 5:00 PM (CEST)
Abstract
Patients with rheumatoid arthritis (RA) can be categorized as either anti-citrullinated protein antibody-positive (ACPA+) or negative (ACPA-). In this webinar, Dr. Sung will present his research exploring a broad range of serological autoantibodies to uncover immunological differences between these RA subgroups using data from ACPA+ RA patients, ACPA- RA patients, and matched healthy controls.
Learning Objectives:
- Learn how 1600+ IgG autoantibodies from serum were screened, yielding biologically relevant and immunologically significant insights.
- Discover the distinct autoantibody profiles identified in ACPA+ and ACPA- patients.
- Understand which proteins and their associated biological processes were predominantly targeted by these autoantibodies.
- Explore the implications of autoantibody biomarkers in RA subgroups and their correlation with the Clinical Disease Activity Index, a measure of disease activity.
- Examine how autoantibody biomarker signatures can enhance patient stratification and diagnostic accuracy in RA.
Webinars will be available for unlimited on-demand viewing after live event.